Exact Mass: 908.2144

Ciliatoside B

C41H48O23 (908.2586)

2,3,4,6-tetra-O-galloyl salidroside|2,3,4,6-Tetra-O-galloylsalidroside

C42H36O23 (908.1647)

3-{[O-3,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1->3)-O-2,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1->6)-beta-D-glucopyranosyl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|kaempferol 3-O-[(3,4-diacetyl)-alpha-L-rhamnopyranosyl(1->3)(2,4-diacetyl)-alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside]|kaempferol 3-O-[3,4-di-O-acetyl-alpha-L-rhamnopyranosyl-(1->3)-2,4-di-O-acetyl-alpha-L-rhamnopyranosyl-(1->6)-]-beta-D-glucopyranoside

C41H48O23 (908.2586)

Carthamin

C44H44O21 (908.2375)

3-{[O-3,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1->3)-O-2,4-di-O-acetyl-6-deoxy-alpha-L-mannopyranosyl-(1->6)-beta-D-glucopyranosyl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|kaempferol 3-O-[3,4-di-O-acetyl-alpha-L-rhamnopyranosyl-(1->3)-2,4-di-O-acetyl-alpha-L-rhamnopyranosyl-(1->6)-]-beta-D-glucopyranoside

C41H48O23 (908.2586)

Breviscapin

C42H36O23 (908.1647)

Neomycin sulfate

C23H52N6O25S3 (908.2144)

Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis[1][2]. Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis[1][2].

Framycetin sulfate

C23H52N6O25S3 (908.2144)

Siroheme amide

C42H38FeN5O15-9 (908.1714)

GlcNAc(S)-Gal-GlcNAc(S)-Gal

C28H48N2O27S2 (908.1886)

beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-6-O-phosphono-beta-D-galactosyl-(1->4)-alpha-D-mannose

C30H53O29P (908.241)

Pentamannose 6-phosphate

C30H53O29P (908.241)

6-O-sulfo-beta-D-glucosyl-(1->3)-[6-O-sulfo-beta-D-glucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->6)]-N-acetyl-beta-D-galactosamine

C28H48N2O27S2 (908.1886)

Gal(b1-4)GlcNAc6S(b1-3)Gal(b1-4)GlcNAc6S

C28H48N2O27S2 (908.1886)

Gal(b1-4)GlcNAc6S(b1-3)Gal(b1-4)b-GlcNAc6S

C28H48N2O27S2 (908.1886)

Pregabalin-CoA; (Acyl-CoA); [M+H]+

C29H51N8O17P3S (908.2306)

beta-D-GlcpNAc6S-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S-(1->3)-D-Galp

C28H48N2O27S2 (908.1886)

An amino tetrasaccharide comprised of two N-acetylated glucosamine residues sulfated on O-6, of which one is at the non-reducing end, and two galactosyl residues, of which one is at the reducing end. It is an intermediate in the keratan sulfate degradation pathway.

PIP3(22:1)

C31H60O22P4 (908.2527)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

9-(2h-1,3-benzodioxol-5-yl)-4-{[(2s,3r,4s)-3-{[(2s,3r,4s,5s)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-4-hydroxy-4-({[(2s,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxolan-2-yl]oxy}-6,7-dimethoxy-3h-naphtho[2,3-c]furan-1-one

C41H48O23 (908.2586)

6-[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]-5-hydroxy-2-methyl-4-{[3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-3-yl acetate

C41H48O23 (908.2586)

9-(2h-1,3-benzodioxol-5-yl)-4-{[(2s,3r,4r)-3-{[(2s,3r,4s,5s)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-4-hydroxy-4-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxolan-2-yl]oxy}-6,7-dimethoxy-3h-naphtho[2,3-c]furan-1-one

C41H48O23 (908.2586)

9-(2h-1,3-benzodioxol-5-yl)-4-({3-[(4-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl)oxy]-4-hydroxy-4-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxolan-2-yl}oxy)-6,7-dimethoxy-3h-naphtho[2,3-c]furan-1-one

C41H48O23 (908.2586)

2-[2-(4-hydroxyphenyl)ethoxy]-4,5-bis(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate

C42H36O23 (908.1647)

9-(2h-1,3-benzodioxol-5-yl)-4-{[(2s,3r,4r)-3-{[(2r,3s,4r,5r)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-4-hydroxy-4-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxolan-2-yl]oxy}-6,7-dimethoxy-3h-naphtho[2,3-c]furan-1-one

C41H48O23 (908.2586)

(2s,3s,4s,5r,6r)-6-{[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-5-hydroxy-2-methyl-4-{[(2s,3r,4r,5s,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-3-yl acetate

C41H48O23 (908.2586)

(2r,3r,4s,5r,6r)-2-[2-(4-hydroxyphenyl)ethoxy]-4,5-bis(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate

C42H36O23 (908.1647)

3-(acetyloxy)-6-{[3,5-bis(acetyloxy)-2-[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]-6-methyloxan-4-yl]oxy}-5-hydroxy-2-methyloxan-4-yl acetate

C41H48O23 (908.2586)

(2s,3s,4s,5r,6s)-3-(acetyloxy)-6-{[(2r,3r,4r,5s,6s)-3,5-bis(acetyloxy)-2-{[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-6-methyloxan-4-yl]oxy}-5-hydroxy-2-methyloxan-4-yl acetate

C41H48O23 (908.2586)